Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.20%
1,108.23
-2.24
-0.20%
—1,110.471,107.751,111.341,093.81——
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
605.63
+1.56
+0.26%
—604.07604.07606.04600.91——
SIXE
Energy
SIXE
Energy
SIXE
+0.70%
1,209.95
+8.46
+0.70%
—1,201.491,205.921,215.311,201.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.40%
1,758.23
-7.07
-0.40%
—1,765.301,764.031,764.031,736.40——
SIXM
Financials
SIXM
Financials
SIXM
+0.72%
634.94
+4.52
+0.72%
—630.42630.34636.69626.03——
SIXR
Staples
SIXR
Staples
SIXR
+1.30%
852.37
+10.92
+1.30%
—841.45843.60858.11840.11——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.01%
218.85
+0.020
+0.01%
—218.83218.83219.32217.33——
SIXT
Technology
SIXT
Technology
SIXT
-1.50%
3,528.49
-53.74
-1.50%
—3,582.233,550.603,562.623,447.78——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
914.82
+0.93
+0.10%
—913.89912.75918.12906.67——
SIXV
Health care
SIXV
Health care
SIXV
+1.93%
1,472.27
+27.94
+1.93%
—1,444.331,446.871,480.741,446.30——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.93%
2,390.61
-22.35
-0.93%
—2,412.962,403.992,411.412,373.90——
Q4 2026 earnings • released • Revenue beat +4.68%
See results
4528:TYO
Ono Pharmaceutical Co Ltd
¥2,479.00
+0.69%
(+17.00) 1D
May 12, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4528...
Open
¥2,466
High
¥2,510
Low
¥2,454
Mkt. cap
1.24T
Avg. vol.
1.79M
Volume
1.52M
Dividend
3.23%
Quarterly dividend
¥20
Ex dividend date
Sep 29, 2025
P/E ratio
16.70
52-wk high
¥2,674
52-wk low
¥1,474
EPS
¥148
Shares outstanding
514.12M
No. of employees
4K
News stories
From sources across the web
Profile
Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948. Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia
About Ono Pharmaceutical Co Ltd
CEOGyo Sagara | Gyo Sagara
Employees4.29K
Founded1717
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Websiteono-pharma.com
Last report
May 8, 2026
Fiscal Period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
118.75B / 113.44B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
127.54B
129.60B
139.90B
118.75B
Cost of goods sold
37.01B
34.96B
36.68B
33.06B
Cost of revenue
37.01B
34.96B
36.68B
33.06B
Research and development expenses
36.25B
34.77B
33.53B
42.49B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.09B
30.08B
31.73B
30.79B
Operating expense
68.53B
64.56B
67.00B
81.75B
Total operating expenses
105.54B
99.53B
103.68B
114.80B
Operating income
22.00B
30.07B
36.22B
3.94B
Other non operating income
-
-
-
1.00M
EBT including unusual items
22.65B
29.52B
37.20B
3.28B
EBT excluding unusual items
22.65B
29.52B
37.20B
3.28B
Income tax expense
5.02B
7.17B
8.31B
2.24B
Effective tax rate
22.16%
24.30%
22.35%
68.23%
Other operating expenses
1.19B
-291.00M
1.73B
8.47B
Net income
17.67B
22.42B
28.86B
818.00M
Net profit margin
13.86%
17.30%
20.63%
0.69%
Earnings per share
-
-
-
-
Interest and investment income
1.43B
677.00M
1.39B
464.00M
Interest expense
-773.00M
-1.23B
-408.00M
-1.13B
Net interest expenses
655.00M
-549.00M
979.00M
-668.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
31.23B
39.39B
45.82B
13.55B
Gain or loss from assets sale
-
-
-
2.20B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer